WEKO3
アイテム
{"_buckets": {"deposit": "20eedc40-7418-48b9-aa6b-f70dbe61c580"}, "_deposit": {"created_by": 1, "id": "66395", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "66395"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00066395", "sets": ["29"]}, "author_link": ["653311", "653310"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2017-08-29", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Recently, 211At has received increasing attention as a potential radionuclide for cancer radioimmunotherapy. It is α-particle emitter, which is extremely effective against malignant cells. We demonstrate a method to verify the efficiency of 211At-labeled trastuzumab antibodies (211At-trastuzumab) against HER2 antigens, which has not been determined for radioimmunotherapy. A CR-39 plastic nuclear detector is used for measuring the position and the linear energy transfer (LET) of individual 211At α- particle tracks. The tracks and 211At-trastuzumab-binding cells were co-visualized by using the geometric information recorded on the CR-39. HER2-positive human gastric cancer cells (NCI-N87), labelled with 211At-trastuzumab, were dropped on the centre of the CR-39 plate. Microscope images of the cells and the corresponding α-tracks acquired by position matching were obtained. The distribution of number of α-particles emitted from single cells suggests that 80% of the 211At-trastuzumab-binding cells emitted α-particles. It also indicates that the α-particles may strike the cells several times along their path. The track-averaged LET of the α-particles is evaluated to be 131 keV/µm. These results will enable quantitative evaluation of delivered doses to target cells, and will be useful for the in vitro assessment of 211At-based radioimmunotherapeutic agents.We will present the current status of radiation dosimetry of α-particle emission from 211At-labeled antibodies in single cells for the in vitro assessment of 211At-based radioimmunotherapeutic agents.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "27th International Conference on Nuclear Tracks and Radiation Measurements", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kodaira, Satoshi"}], "nameIdentifiers": [{"nameIdentifier": "653310", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小平 聡", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "653311", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Radiation dosimetry of α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Radiation dosimetry of α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/66395", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-09-04"}, "publish_date": "2017-09-04", "publish_status": "0", "recid": "66395", "relation": {}, "relation_version_is_last": true, "title": ["Radiation dosimetry of α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors"], "weko_shared_id": -1}
Radiation dosimetry of α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors
https://repo.qst.go.jp/records/66395
https://repo.qst.go.jp/records/663950e980ed8-05f0-4df3-a37b-3fe0692bd93b
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-09-04 | |||||
タイトル | ||||||
タイトル | Radiation dosimetry of α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kodaira, Satoshi
× Kodaira, Satoshi× 小平 聡 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Recently, 211At has received increasing attention as a potential radionuclide for cancer radioimmunotherapy. It is α-particle emitter, which is extremely effective against malignant cells. We demonstrate a method to verify the efficiency of 211At-labeled trastuzumab antibodies (211At-trastuzumab) against HER2 antigens, which has not been determined for radioimmunotherapy. A CR-39 plastic nuclear detector is used for measuring the position and the linear energy transfer (LET) of individual 211At α- particle tracks. The tracks and 211At-trastuzumab-binding cells were co-visualized by using the geometric information recorded on the CR-39. HER2-positive human gastric cancer cells (NCI-N87), labelled with 211At-trastuzumab, were dropped on the centre of the CR-39 plate. Microscope images of the cells and the corresponding α-tracks acquired by position matching were obtained. The distribution of number of α-particles emitted from single cells suggests that 80% of the 211At-trastuzumab-binding cells emitted α-particles. It also indicates that the α-particles may strike the cells several times along their path. The track-averaged LET of the α-particles is evaluated to be 131 keV/µm. These results will enable quantitative evaluation of delivered doses to target cells, and will be useful for the in vitro assessment of 211At-based radioimmunotherapeutic agents.We will present the current status of radiation dosimetry of α-particle emission from 211At-labeled antibodies in single cells for the in vitro assessment of 211At-based radioimmunotherapeutic agents. | |||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 27th International Conference on Nuclear Tracks and Radiation Measurements | |||||
発表年月日 | ||||||
日付 | 2017-08-29 | |||||
日付タイプ | Issued |